glutathione and glutathione-s-transferase in detoxification mechanisms S-transferase π: a potential role antitumor therapy | DDDT RCSB PDB - 1AQW: GLUTATHIONE

After 9 weeks of therapy, patient developed worsening jaundice, rise in total and conjugated bilirubin (5.3mg/dL and 2.1mg/dL, respectively), and hypopigmented stools when transitioned from infant to pediatric hydrolyzed formula

Then the single positive clones from the RMG plates were picked up, and 150 single clones were used for screening the GST inhibitors

Patients with Fitzpatrick IV to VI skin should treat conservatively initially with patch tests because of slightly elevated post-inflammatory hyperpigmentation risk

In a series of 167 children with hematologic malignancy or aplastic anemia receiving dapsone for Pneumocystis (PCP) prophylaxis, 32 (19 percent) developed methemoglobinemia (median level: 9 percent, range 3.5 to 22 percent)

We observed a complete inhibition of the cell proliferation of NCI-H1299, NCI-H125, NCI-H520, NCI-HCC15 with the combination treatment, which was slightly less robust in NCI-H1975, and Calu-6 cell lines